Alzheimers Dement

1. ALBALA B, Appelmans E, Burress R, De Santi S, et al
   The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).
   Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13483.
   

   >> Share

   
   
2. 
   AAIC 2023: Discoveries propel Alzheimer's diagnosis and clinical care.
   Alzheimers Dement. 2023 Oct 3. doi: 10.1002/alz.13487.
   

   >> Share

   
   
3. WALKER JM, Orr ME, Orr TC, Thorn EL, et al
   Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.
   Alzheimers Dement. 2023 Sep 30. doi: 10.1002/alz.13484.
   

   >> Share

   
   
4. ERASLAN BOZ H, Kocoglu K, Akkoyun M, Tufekci IY, et al
   Visual search in Alzheimer's disease and amnestic mild cognitive impairment: An eye-tracking study.
   Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13478.
   

   >> Share

   
   

   
   Am J Geriatr Psychiatry

5. FU JF
   Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET: A Commentary on Silva-Rudberg et al.
   Am J Geriatr Psychiatry. 2023 Sep 14:S1064-7481(23)00408.
   

   >> Share

   
   

   
   Ann Neurol

6. SHAW LM, Galasko D
   Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD.
   Ann Neurol. 2023;94:618-619.
   

   >> Share

   
   
7. SOLDAN A, Oh S, Ryu T, Pettigrew C, et al
   NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment.
   Ann Neurol. 2023;94:620-631.
   

   >> Share

   
   

   
   Biol Psychiatry

8. LU Z, Yue W
   Multiple Functional Variants and Genes at a Single Locus for Alzheimer's Disease.
   Biol Psychiatry. 2023;94:692-693.
   

   >> Share

   
   
9. REUS LM, Ophoff RA
   Novel Risk Locus Influences Risk to Clinical Progression to Alzheimer's Disease-type Dementia: A Step Toward the Disentanglement of Heterogeneity in Progression.
   Biol Psychiatry. 2023;94:689-691.
   

   >> Share

   
   

   
   BMC Neurol

10. LI Z, Wu H, Luo Y, Tan X, et al
    Correction: Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity.
    BMC Neurol. 2023;23:347.
    

    >> Share

    
    

    
    Brain

11. KEPP KP, Robakis NK, Hoilund-Carlsen PF, Sensi SL, et al
    The amyloid cascade hypothesis: an updated critical review.
    Brain. 2023;146:3969-3990.
    

    >> Share

    
    
12. DU F, Yu Q, Swerdlow RH, Waites CL, et al
    Glucocorticoid-driven mitochondrial damage stimulates Tau pathology.
    Brain. 2023;146:4378-4394.
    

    >> Share

    
    
13. BANERJEE G, Collinge J, Fox NC, Lashley T, et al
    Clinical considerations in early-onset cerebral amyloid angiopathy.
    Brain. 2023 Jun 6:awad193. doi: 10.1093.
    

    >> Share

    
    
14. TUNOLD JA, Tan MMX, Koga S, Geut H, et al
    Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.
    Brain. 2023;146:4077-4087.
    

    >> Share

    
    

    
    Brain Res

15. LIAN X, Zhang X, Chen W, Xue F, et al
    Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
    Brain Res. 2023 Sep 29:148612. doi: 10.1016/j.brainres.2023.148612.
    

    >> Share

    
    
16. MALIK R, Kalra S, Pooja, Singh G, et al
    Antioxidative and neuroprotective potential of Acorus calamus linn. and Cordia dichotoma G. Forst. In Alzheimer's type dementia in rodent.
    Brain Res. 2023 Oct 2:148616. doi: 10.1016/j.brainres.2023.148616.
    

    >> Share

    
    

    
    Dement Geriatr Cogn Disord

17. LI Y, Ren Y, Cong L, Hou T, et al
    Association of Lifelong Cognitive Reserve with Dementia and Mild Cognitive Impairment among Older Adults with Limited Formal Education: A Population-Based Cohort Study.
    Dement Geriatr Cogn Disord. 2023;52:258-266.
    

    >> Share

    
    

    
    Exp Gerontol

18. LIU S, Zhang S, Guo M, Lei Q, et al
    Acoustic stimulation during sleep improves cognition and ameliorates Alzheimer's disease pathology in APP/PS1 mice.
    Exp Gerontol. 2023;182:112299.
    

    >> Share

    
    

    
    Exp Neurol

19. HOSSEININIA M, Rostami F, Delphi L, Ghasemzadeh Z, et al
    Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model.
    Exp Neurol. 2023 Sep 30:114560. doi: 10.1016/j.expneurol.2023.114560.
    

    >> Share

    
    

    
    J Alzheimers Dis

20. DALY T
    Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
    

    >> Share

    
    
21. POLIN C, Gelle T, Auditeau E, Adou C, et al
    Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
    

    >> Share

    
    
22. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
    Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
    

    >> Share

    
    
23. HUA S, Peters BA, Lee S, Fitzgerald K, et al
    Gut Microbiota and Cognitive Function Among Women Living with HIV.
    J Alzheimers Dis. 2023;95:1147-1161.
    

    >> Share

    
    
24. COSTA T, Premi E, Liloia D, Cauda F, et al
    Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
    J Alzheimers Dis. 2023;95:1059-1065.
    

    >> Share

    
    
25. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
    Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;95:829-845.
    

    >> Share

    
    
26. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
    Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
    

    >> Share

    
    
27. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
    Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
    

    >> Share

    
    
28. ROGERS JT, Cahill CM
    Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
    

    >> Share

    
    
29. AL-LAHHAM R, Mendez N
    Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
    J Alzheimers Dis. 2023;95:1041-1058.
    

    >> Share

    
    
30. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
    Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
    J Alzheimers Dis. 2023;95:931-940.
    

    >> Share

    
    
31. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
    Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
    J Alzheimers Dis. 2023;95:1067-1075.
    

    >> Share

    
    

    
    JAMA Intern Med

32. BRENDER TD
    Chatbot Confabulations Are Not Hallucinations-Reply.
    JAMA Intern Med. 2023;183:1177-1178.
    

    >> Share

    
    

    
    Nat Neurosci

33. WISEMAN S
    Liraglutide and learning.
    Nat Neurosci. 2023;26:1660.
    

    >> Share

    
    

    
    Neuro Endocrinol Lett

34. CHENG X, Ding M, Wei C, Xiao F, et al
    The effect of hypoxia on Hydrogen Sulfide concentration of brain tissue in AD transgenic mice and its mechanism.
    Neuro Endocrinol Lett. 2023;44:193-198.
    

    >> Share

    
    

    
    Neurology

35. LEWIS A, Gupta A, Oh I, Schindler SE, et al
    Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic.
    Neurology. 2023;101:e1424-e1433.
    

    >> Share

    
    
36. PARNETTI L, Bellomo G
    Advances in Diagnosis and Prognosis of Parkinson Disease: Value of Cerebrospinal Fluid Proteomics.
    Neurology. 2023 Aug 16:10.1212/WNL.0000000000207724.
    

    >> Share

    
    
37. GANESH A, Galetta S
    Editors' Note: Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease.
    Neurology. 2023;101:633.
    

    >> Share

    
    
38. OVEISGHARAN S, Bennett DA
    Author Response: Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease.
    Neurology. 2023;101:634.
    

    >> Share

    
    
39. BRENNER S
    Reader Response: Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease.
    Neurology. 2023;101:633-634.
    

    >> Share

    
    

    
    Neuroscience

40. ELDEEN MAKKI B, Rahman S
    Erratum to "Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect" [Neuroscience 530 (2023) 79-94].
    Neuroscience. 2023 Sep 26:S0306-4522(23)00427.
    

    >> Share

    
    

    
    PLoS One

41. NGUYEN TTT, Lee HH, Huang LK, Hu CJ, et al
    Heterogeneity of Alzheimer's disease identified by neuropsychological test profiling.
    PLoS One. 2023;18:e0292527.
    

    >> Share

    
    
42. ZHANG GH, Chin KL, Yan SY, Pare R, et al
    Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.
    PLoS One. 2023;18:e0287817.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share